Ember Therapeutics
Mr. Hernandez, the current Executive Chairman and member of the board of directors, was at Merck and has been involved in the management and founding of several early-stage biotechnology companies, including Affymetrix, Digene (now Qiagen), Innovative Biosciences, Inc., Signal Genetics, LLC and Microlin Bio, Inc.
This person is not in any offices
Ember Therapeutics
Ember Therapeutics is a product-focused company translating its world-class biology in the emerging area of brown fat and recent breakthroughs in understanding the mechanisms of selective insulin sensitivity into a proprietary pipeline of peripherally-acting treatments for metabolic disease, including Type 2 diabetes and obesity.